Skip to main content

Table 4 Association between methylation levels of PDCD-1, LAG-3 in PBL and CRC risk

From: Inhibitory immune checkpoints PDCD-1 and LAG-3 hypermethylation may reduce the risk of colorectal cancer

Gene

Hypomethylation

Hypermethylation

OR (95%CI)

*P value

ORadj (95%CI)

*P value

PDCD-1

 CRCs (n = 389), n%

159 (40.87%)

230 (59.13%)

 

< 0.0001

 

< 0.0001

 Controls (n = 386), n%

92 (23.83%)

294 (76.17%)

0.453 (0.332–0.617)

 

0.448 (0.322–0.622)

 

LAG-3

 CRCs (n = 390), n%

169 (43.33%)

221 (56.67%)

 

< 0.0001

 

< 0.0001

 Controls (n = 397), n%

108 (27.20%)

289 (72.80%)

0.489 (0.363–0.659)

 

0.417 (0.301–0.578)

 
  1. *P values < 0.05 were considered statistically significant and were indicated in bold
  2. CRC, colorectal cancer; CI, confidence interval; OR, odds ratio; ORadj: adjusted for age, gender